Joseph L. Herring is president and chief operating officer for Covance, one of the world’s largest and most comprehensive drug development services companies. Herring has operating responsibility for all of Covance’s business units worldwide, including Early Development, Clinical Development, Central Labs, and Commercialization Services.

Herring earned his bachelor of science in business administration from LSU in 1978. Herring had an 18 year career with American Hospital Supply/Baxter/Caremark, where he served as vice president /general manager of the oncology services division, area vice president, and vice president of marketing. He joined Covance in 1996. Herring held both the senior vice president and president positions in the Early Development Services unit, and was instrumental in turning that unit into one of Covance’s top financial performers. He was named president and chief operating officer in 2001, and in 2004 was elected to Covance’s board of directors.

In addition to serving on Covance’s board of directors, Herring also serves on the board of directors for First Circle Medical in Minneapolis, a drug development company working on proprietary technology to treat Hepatitis C.

See Calendar of Events for event details.